Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).

PHASE2CompletedINTERVENTIONAL
Enrollment

521

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

October 7, 2024

Study Completion Date

March 7, 2025

Conditions
Psoriasis
Interventions
DRUG

HRO350

Active substance phospholipid esters from herring roe oil (PEHeRo)

DRUG

Placebo

Placebo; as a sunflower oil in capsules similar to the interventional drug product HRO350 in terms of appearance, smell and taste.

Trial Locations (49)

Unknown

CRST Helsinki Oy, Helsinki

CRST Turku Oy, Turku

Fachklinik, Bad Bentheim

Hautmedizin Bad Soden Studienzentrum GmbH, Bad Soden

Hautarztpraxis Dr Wildfeuer, Berlin

Isa Research - Interdisciplinary Study Organisation, Berlin

Universitätsklinikum Dresden Klinik und Poliklinik für Dermatologie, Dresden

Proderma, Institut für klinische Studien und innovative Dermatologie, Dülmen

Universitätsklinikum Essen, Essen

Derma-Study-Centre, Friedrichshafen

Universitätsklinikum Heidelberg, Heidelberg

University Clinic UKSH Kiel, Kiel

Klinikum der Universität München, Munich

Universitätsklinikum Münster, Münster

Dermatologisches Studienzentrum Hunsrück am Haut -und Laserzentrum, Simmern

Hautarztpraxis Dr. Leitz - Studienzentrum Triderm, Stuttgart

Hautarztpraxis Dr. med. Matthias Hoffmann, Witten

Ålesund Hospital, Ålesund

Haukeland University Hospital, Haukeland

Centrum Medyczne All-Med, Krakow

KO-MED Centra Medyczne, Puławy

MICS Centrum Medyczne, Torun

Narodowy Instytut Geriatrii, Warsaw

The Practice of Health, Barry

Heart of Bath Medical Partnership, Bath

Waterloo Medical Centre, Blackpool

St Luke's Hospital, Bradford

Concord Medical Centre, Bristol

Royal Primary Care Ashgate, Chesterfield

Hathaway Medical Centre, Chippenham

Rowden Surgery, Chippenham

Lakeside Healthcare Research, Corby

University Hospital of North Durham, Durham

Haven Health, Felixstowe

Honiton Surgery, Honiton

Oak Tree Surgery, Liskeard

Babylon Healthcare GP at Hand, London

Luton and Dunstable University Hospital, Luton

Kiltearn Medical Centre, Nantwich

Newquay Health Centre, Newquay

St Clare Medical Centre, Penzance

University Hospitals Dorset, Poole

Clarence House Medical Centre, Rhyl

Sherbourne Medical Practice, Royal Leamington Spa

Salford Royal Hospital, Salford

Kings Mill Hospital, Sutton in Ashfield

Grove Surgery, Thetford

Trowbridge Health Centre, Trowbridge

West Walk Surgery, Yate

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Smerud Medical Research International AS

OTHER

lead

Arctic Bioscience

INDUSTRY

NCT06125808 - Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study). | Biotech Hunter | Biotech Hunter